Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE GUYOMARC'H COLPIN HAY : revenue, balance sheet and financial ratios

PHARMACIE GUYOMARC'H COLPIN HAY is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LA VILLE-AUX-DAMES (37700), this company of category PME shows in 2016 a revenue of 642 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE GUYOMARC'H COLPIN HAY (SIREN 498130178)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C 641 509 €
Net income 136 435 € 109 034 € 189 040 € 182 254 € 166 125 € 160 091 € 248 033 € 117 542 € 50 672 € 36 151 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C 39 462 €
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C 5.6%

Revenue and income statement

In 2025, PHARMACIE GUYOMARC'H COLPIN HAY generates positive net income of 136 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 36 k€ -> 136 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

136 435 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 32%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

32.035%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

66.489%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

17.1%

Solvency indicators evolution
PHARMACIE GUYOMARC'H COLPIN HAY

Sector positioning

Debt ratio
32.03 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good -9 pts over 3 years

In 2025, the debt ratio of PHARMACIE GUYOMARC'H COLP... (32.03) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
66.49% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good +5 pts over 3 years

In 2025, the financial autonomy of PHARMACIE GUYOMARC'H COLP... (66.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 167.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

167.363

Liquidity indicators evolution
PHARMACIE GUYOMARC'H COLPIN HAY

Sector positioning

Liquidity ratio
167.36 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average -24 pts over 3 years

In 2025, the liquidity ratio of PHARMACIE GUYOMARC'H COLP... (167.36) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE GUYOMARC'H COLPIN HAY

Positioning of PHARMACIE GUYOMARC'H COLPIN HAY in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE GUYOMARC'H COLPIN HAY is estimated at 2 167 286 € (range 1 470 730€ - 3 400 770€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1470k€ 2167k€ 3400k€
2 167 286 € Range: 1 470 730€ - 3 400 770€
NAF 5 année 2025

Valuation method used

Net Income Multiple
136 435 € × 15.9x = 2 167 286 €
Range: 1 470 731€ - 3 400 770€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE GUYOMARC'H COLPIN HAY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE GUYOMARC'H COLPIN HAY

What is the revenue of PHARMACIE GUYOMARC'H COLPIN HAY ?

The revenue of PHARMACIE GUYOMARC'H COLPIN HAY in 2016 is 642 k€.

Is PHARMACIE GUYOMARC'H COLPIN HAY profitable?

Yes, PHARMACIE GUYOMARC'H COLPIN HAY generated a net profit of 136 k€ in 2025.

Where is the headquarters of PHARMACIE GUYOMARC'H COLPIN HAY ?

The headquarters of PHARMACIE GUYOMARC'H COLPIN HAY is located in LA VILLE-AUX-DAMES (37700), in the department Indre-et-Loire.

Where to find the tax return of PHARMACIE GUYOMARC'H COLPIN HAY ?

The tax return of PHARMACIE GUYOMARC'H COLPIN HAY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE GUYOMARC'H COLPIN HAY operate?

PHARMACIE GUYOMARC'H COLPIN HAY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.